20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Diabetic Retinopathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harris, NR; Leskova, W; Wang, Z; Yadav, AS | 1 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Diabetic Retinopathy
| Article | Year |
|---|---|
Inhibition of 20-HETE attenuates diabetes-induced decreases in retinal hemodynamics.
Topics: Amidines; Animals; Blood Flow Velocity; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Erythrocytes; Hydroxyeicosatetraenoic Acids; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Regional Blood Flow; Retinal Vessels | 2011 |